Literature DB >> 25116825

Trends of chronic liver disease in a tertiary care referral hospital in Eastern India.

Gautam Ray1.   

Abstract

BACKGROUND: There is scarce Indian data on time trends of hepatitis, an impediment to formulate an effective public health policy on the matter.
OBJECTIVE: The aim was to study secular trends and burden of hepatitis in a railway population.
MATERIALS AND METHODS: Outdoor, indoor, endoscopy unit and mortality records of patients attending this hospital from January 2003 to December 2011 were searched manually and relevant parameters of hepatitis patients were noted, especially etiology, clinical features, treatment, and mortality. Cochran-Armitage trend test was used to test significance of any trend in these parameters. Binary logistic regression analysis of various factors was carried out to study their effect on the liver related mortality of hepatitis B and C cases and Kaplan-Meyer survival curves were generated for significant factors. Two-sided P < 0.05 was considered to be significant. RESULT: Chronic liver disease (CLD) due to alcohol showed a significant rising trend with early age (mean 48.4 years) and high percentage of decompensated disease (75%) at presentation and high early mortality (63%). No trend was observed for hepatitis B and C, but significant reduction in mortality was observed when definitive therapy was given. Cryptogenic CLD showed a decreasing trend though overall it still remained the most important etiology and survival was better compared with alcohol even with conservative therapy. Only 4% patients had hepatocellular carcinoma.
CONCLUSION: A menace of alcohol related liver disease affecting young productive work force in this part of India is foreseen, which might impact the country's economy and mandates immediate containment policy.

Entities:  

Mesh:

Year:  2014        PMID: 25116825     DOI: 10.4103/0019-557X.138630

Source DB:  PubMed          Journal:  Indian J Public Health        ISSN: 0019-557X


  7 in total

Review 1.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

2.  A Study on the Temporal Trends in the Etiology of Cirrhosis of Liver in Coastal Eastern Odisha.

Authors:  Debakanta Mishra; Kaibalya R Dash; Chittaranjan Khatua; Subhendu Panigrahi; Prasanta K Parida; Sambit K Behera; Rakesh K Barik; Subhasis Pradhan; Saroj K Sahu; Bhaskar Thakur; Shivaram P Singh
Journal:  Euroasian J Hepatogastroenterol       Date:  2020 Jan-Jun

3.  Clinical Presentation and Mortality Determinants of Alcohol-Related Liver Disease: A Single-Center Experience of the Rising Menace from Eastern India.

Authors:  Gautam Ray; P Manjubhargav
Journal:  Inflamm Intest Dis       Date:  2019-07-29

Review 4.  Current Scenario of Hepatitis B and Its Treatment in India.

Authors:  Gautam Ray
Journal:  J Clin Transl Hepatol       Date:  2017-07-08

5.  Cost of Intensive Care Treatment for Liver Disorders at Tertiary Care Level in India.

Authors:  Shankar Prinja; Pankaj Bahuguna; Ajay Duseja; Manmeet Kaur; Yogesh Kumar Chawla
Journal:  Pharmacoecon Open       Date:  2018-06

6.  Alcohol associated liver cirrhotics have higher mortality after index hospitalization: Long-term data of 5,138 patients.

Authors:  Priyanka Jain; Saggere Muralikrishna Shasthry; Ashok Kumar Choudhury; Rakhi Maiwall; Guresh Kumar; Ankit Bharadwaj; Vinod Arora; Rajan Vijayaraghavan; Ankur Jindal; Manoj Kumar Sharma; Vikram Bhatia; Shiv Kumar Sarin
Journal:  Clin Mol Hepatol       Date:  2020-12-03

7.  Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India.

Authors:  Bhaskar Raju; Anar Andani; Shafi Kolhapure; Ashish Agrawal
Journal:  Hum Vaccin Immunother       Date:  2020-11-25       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.